FDA NDC Directory · JSON-LD · Markdown

NYSTATIN

NDC 69315-504 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerLeading Pharma, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA214346
Dosage form / routeSUSPENSION · ORAL
Active ingredientsNYSTATIN (100000 [USP'U]/mL)
Marketing started20221205
Package count2

External sources

Source: openFDA. Public-domain (CC0).